Caribbean

Resilience System


You are here

Data

Iceland: Countering the pandemic, bringing life back to normal

While the rest of the world grapples with mass vaccinations and fear of the new coronavirus variants, life in Iceland is getting closer to normal.

Since the beginning of the month, not a single person has been diagnosed with Covid-19 domestically apart from a handful of people who were already in quarantine.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

ANALYSIS: There is a chance to stop the coronavirus from making a big comeback after recent decline

Across the United States, and the world, the coronavirus seems to be loosening its stranglehold. The deadly curve of cases, hospitalizations and deaths has yo-yoed before, but never has it plunged so steeply and so fast.

Is this it, then? Is this the beginning of the end? After a year of being pummeled by grim statistics and scolded for wanting human contact, many Americans feel a long-promised deliverance is at hand.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

COVIS-19 Survivors have estimated 10 fold increase in protection--study

COVID-19 survivors tend to have a roughly tenfold increase in protection against the virus, according to a government-funded study published Wednesday.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

FDA says Johnson and Johnson vaccine provides protection against Covid, a step toward final decision

FDA says J&J 1-dose shot prevents COVID; final decision soon

WASHINGTON (AP) — Johnson & Johnson’s single-dose vaccine protects against COVID-19, according to an analysis by U.S. regulators Wednesday that sets the stage for a final decision on a new and easier-to-use shot to help tame the pandemic.

The Food and Drug Administration’s scientists confirmed that overall the vaccine is about 66% effective at preventing moderate to severe COVID-19. The agency also said J&J’s shot — one that could help speed vaccinations by requiring just one dose instead of two — is safe to use.

That’s just one step in the FDA’s evaluation of a third vaccine option for the U.S. On Friday, the agency’s independent advisers will debate if the evidence is strong enough to recommend the long-anticipated shot. Armed with that advice, FDA is expected to make a final decision within days. ...

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Pages

Subscribe to Data
howdy folks
Page loaded in 0.932 seconds.